| 000 | 01518 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514231158.0 | ||
| 264 | 0 | _c20060321 | |
| 008 | 200603s 0 0 rus d | ||
| 022 | _a0022-9040 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSirotkina, O V | |
| 245 | 0 | 0 |
_a[Clinical value of allele variants of cytochrome CYP2C9 gene for anticoagulation therapy with warfarin]. _h[electronic resource] |
| 260 |
_bKardiologiia _c2005 |
||
| 300 |
_a61-3 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
| 650 | 0 | 4 |
_aAryl Hydrocarbon Hydroxylases _xgenetics |
| 650 | 0 | 4 | _aCytochrome P-450 CYP2C9 |
| 650 | 0 | 4 |
_aDNA _xgenetics |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aGene Frequency |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 | _aRussia |
| 650 | 0 | 4 |
_aThrombosis _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUrban Population |
| 650 | 0 | 4 |
_aWarfarin _xadministration & dosage |
| 700 | 1 | _aUlitina, A S | |
| 700 | 1 | _aTaraskina, A E | |
| 700 | 1 | _aKadinskaia, M I | |
| 700 | 1 | _aVavilova, T V | |
| 700 | 1 | _aPchelina, S N | |
| 700 | 1 | _aShvarts, E I | |
| 773 | 0 |
_tKardiologiia _gvol. 45 _gno. 4 _gp. 61-3 |
|
| 999 |
_c15600314 _d15600314 |
||